Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kailera Therapeutics, Inc. - Common stock (NQ:KLRA)

19.79 -1.20 (-5.74%)
Streaming Delayed Price Updated: 12:49 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kailera Therapeutics, Inc. - Common stock

News headline image
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
From Kailera Therapeutics, Inc.
Via GlobeNewswire
News headline image
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
From Kailera Therapeutics, Inc.
Via GlobeNewswire
News headline image
Is Kailera Therapeutics a Buy After Its Sizzling IPO? ↗
There's a new challenger to the more established players in the weight-loss drug space. 
Via The Motley Fool
Topics Initial Public Offering
News headline image
A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million ↗
Kailera Therapeutics, a clinical-stage biotech focused on obesity treatments, just reported a notable insider buy in recent SEC filings. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Kailera Therapeutics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.